We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok ✕
Testing therapeutic candidates in patient-derived brain organoids modeling Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia.
Microgravity can accelerate brain organoid maturation and changes associated with aging and neurodegeneration. These accelerated models allow researchers to evaluate therapeutic candidates on a shorter timescale while capturing differences across patient donors.
Space Tango’s CubeLab houses multi-well culture plates containing brain organoids from diverse patient donors. Automated operations support parallel testing of Sachi Bio’s therapeutics addressing three disease models. Returned samples undergo analysis to assess treatment effects on neurodegeneration, inflammation, and other disease-related changes.
Findings could accelerate discovery of treatments for neurodegenerative diseases. Testing candidates in human tissue from diverse donors may improve prediction of patient responses and reduce reliance on animal models.
Investigating whether microgravity enables stem cell-derived liver organoids to assemble into larger, functional tissues with blood vessel networks.
Microgravity provides persistent culture conditions with low shear stress that may help liver organoids self-organize into larger, more complex tissues. Researchers will examine whether these conditions support formation of blood vessel networks that can carry fluid through the tissue.
Space Tango’s CubeLab houses the Tissue Orb, a specialized bioreactor designed for tissue self-assembly and blood vessel formation. Liver organoids derived from induced pluripotent stem cells carry out autonomous operations on the ISS. After the experiment, samples return to Earth in cold storage for analysis.
Findings could advance methods for producing functional liver tissues and developing new therapies for severe liver dysfunction. This work may support future alternatives to donor organ transplantation and help address the shortage of available livers.
Studying how microgravity affects human heart and blood vessel tissues using a miniature cardiovascular chip.
Extended exposure to microgravity can produce cardiovascular changes similar to those associated with aging, including arterial stiffening and impaired heart relaxation. Studying these changes in human tissue models could reveal how stiffness-related heart disease develops.
Space Tango’s CubeLab houses cardiovascular chips containing heart and blood vessel tissues derived from human stem cells. A microfluidic system connects the tissues, while automated pressure control and video monitoring track their function. After return, researchers compare tissue and fluid samples with ground controls to identify disease biomarkers and underlying mechanisms.
Findings could support new treatments for arterial stiffening and impaired heart function in aging populations. This research may also inform countermeasures to protect human cardiovascular health during long-duration space missions.
Evaluating microgravity manufacturing of protein-based retinal implants designed to restore meaningful vision.
Microgravity may reduce protein aggregation and sedimentation during layer-by-layer assembly of artificial retinas. Researchers will examine whether these conditions produce more uniform, stable films and improve implant performance.
A specialized Space Tango Mambo Tray automates layer-by-layer deposition of experimental fluids to manufacture protein-based artificial retinas. The system operates autonomously inside the Mambo facility on the ISS and captures images throughout production. The tray returns to Earth after operations for further evaluation.
LambdaVision’s artificial retina aims to restore meaningful vision for people with retinal degenerative diseases, including retinitis pigmentosa and age-related macular degeneration. Improved manufacturing could support development and production of more consistent retinal implants for patients on Earth.
Validating a multicellular human brain tissue model for studying neurological responses to spaceflight.
Spaceflight exposes astronauts to microgravity and radiation that may affect brain cell function and health. Studying human brain tissue on the ISS allows researchers to examine these biological effects and evaluate it as a platform for future neurological risk assessment.
Space Tango’s CubeLab maintains stem cell-derived mini brain tissues containing multiple major human brain cell types. Automated environmental control and imaging support tissue viability monitoring throughout the mission. After return, researchers analyze cellular and molecular changes to assess tissue health and the effects of spaceflight.
Findings could guide future countermeasures to protect astronaut brain health. The mini brain platform may also support personalized treatment testing and improve disease modeling for Alzheimer’s, Parkinson’s, and other neurological disorders on Earth.
Studying how microgravity affects wound healing using 3D tissue models.
Wound healing depends on coordination between new blood vessel formation and remodeling of the extracellular matrix – the structural network surrounding cells. Microgravity allows researchers to examine how this coordination changes and how those changes may affect tissue regeneration and scar formation.
A sensor-integrated 3D tissue model combines fibroblasts and endothelial cells to mimic a wound healing environment. The autonomous system measures tissue stiffening in real time so researchers may study collagen production, blood vessel network formation, and changes in gene and protein expression.
Findings could improve wound healing research and inform treatments for chronic wounds, burns, and surgical recovery. The technology may also support tissue engineering and drug testing platforms that better replicate human healing.
Coordinated cellular responses to the space environment in cancer and immune organoids.
Microgravity enables organoids to develop more uniform, complex structures that better represent human tissues. These models help researchers examine how immune cells support or fight glioblastoma, an aggressive brain cancer, and how immune cells alone respond to the stresses of spaceflight.
Space Tango’s High-Capacity Sample CubeLab supports controlled growth of cancer-immune and immune-only organoids for more than 30 days on orbit. Researchers combine glioblastoma and myeloid immune cells in different proportions and states. After return, they compare the organoids with ground controls to assess changes in growth and cell behavior.
Findings could improve understanding of brain tumor immune function and immunity dysfunction. More representative tissue models may support development and testing of new therapies while reducing reliance on animal testing.
Evaluating an investigational therapy in patient-derived tumor organoids to study cancer progression and treatment resistance.
Microgravity enables accelerated disease modeling and testing of different dosing strategies. The space environment can activate ADAR1p150, a protein associated with cancer stem cell growth, metastasis, and immune evasion, providing a model for evaluating therapies that block its production.
Space Tango’s CubeLab maintains patient-derived cancer cells in nanobioreactors for a one-month investigation. Researchers treat cells with rebecsinib before integration and use fluorescent reporters to measure changes in immune response and function. A matching CubeLab on Earth provides a ground control.
Findings could advance therapies targeting cancer stem cells and treatment resistance. The research may also inform cancer detection and relapse prevention strategies, with the potential to improve patient outcomes on Earth.